Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the major cause of early-onset familial Parkinson's disease. To investigate the pathogenic mechanism by which loss of parkin function causes Parkinson's disease, we generated a mouse model bearing a germline disruption in parkin. Parkin-/- mice are viable and exhibit grossly normal brain morphology. Quantitative in vivo microdialysis revealed an increase in extracellular dopamine concentration in the striatum of parkin-/- mice. Intracellular recordings of medium-sized striatal spiny neurons showed that greater currents are required to induce synaptic responses, suggesting a reduction in synaptic excitability in the absence of parkin. Furthermore, parkin-/- mice exhibit deficits in behavioral paradigms sensitive to dysfunction of the nigrostriatal pathway. The number of dopaminergic neurons in the substantia nigra of parkin-/- mice, however, is normal up to the age of 24 months, in contrast to the substantial loss of nigral neurons characteristic of Parkinson's disease. Steady-state levels of CDCrel-1, synphilin-1, and alpha-synuclein, which were identified previously as substrates of the E3 ubiquitin ligase activity of parkin, are unaltered in parkin-/- brains. Together these findings provide the first evidence for a novel role of parkin in dopamine regulation and nigrostriatal function, and a non-essential role of parkin in the survival of nigral neurons in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, parkin-deficient mice and mice expressing a dominant negative form of Nrdp1 are not reported to have significant neurodegenerative disease171819.”
From Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival (2016) · cites this paper as [18]
In the citing paper
“The lack of reported neurodegeneration in parkin-deficient and Nrdp1 mutant mice171819 makes it unlikely that this interaction explains our finding of neurodegeneration in Clec16a mutant mice.”
From Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival (2016) · cites this paper as [18]
In the citing paper
“Although PINK1 (McWilliams et al, 2018) and PRKN (Goldberg et al, 2003; Perez & Palmiter, 2005) deficiency do not elicit major defects under baseline conditions, defective striatal neural plasticity is observed in prkn− / − mice (Kitada et al, 2009).”
From Autophagy in major human diseases (2021) · cites this paper as Goldberg et al, 2003
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The unbiased estimation of number and sizes of arbitrary particles using the disector
Sterio, D. C. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb02501.x · Cited by 2,519
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Dunham, N. W., & Miya, T. S. (1957) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030460322 · Cited by 1,716
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L., & Bland, S. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00005-8 · Cited by 1,354
Self-citationNeuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Self-citationThe oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784
Self-citationImai, Y., Soda, M., & Takahashi, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000447200 · Cited by 766
Identifying Multiple Outliers in Multivariate Data
Hadi, A. S. (1992) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1992.tb01449.x · Cited by 761
Chung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1144 · Cited by 750
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Neuropathology in mice expressing human alpha-synuclein
van der Putten, H., Wiederhold, K., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Rüegg, M. A., et al. (2000) · PubMed · doi:10.5451/unibas-ep2767 · Cited by 505
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
Neuropathology in Mice Expressing Human α-Synuclein
van der Putten, H., Wiederhold, K.-H., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Ruegg, M. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06021.2000 · Cited by 477
(2002) · doi:10.1016/s0896-6273(02)01125-x · Cited by 473
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370
Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila
Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., & Lu, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00143-0 · Cited by 364
Schallert, T., Upchurch, M., Lobaugh, N., Farrar, S. B., Spirduso, W. W., Gilliam, P., Vaughn, D., & Wilcox, R. E. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90452-x · Cited by 326
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Self-citationKlapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M.-F., & Levine, M. S. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.6.2667 · Cited by 314
Self-citationConstraints on reinitiation of translation in mammals
Kozak, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.24.5226 · Cited by 303
Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440612 · Cited by 296
Behavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice
Richfield, E. K., Thiruchelvam, M. J., Cory-Slechta, D. A., Wuertzer, C., Gainetdinov, R. R., Caron, M. G., Di Monte, D. A., & Federoff, H. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7882 · Cited by 285
Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation.
Ren, Y., Zhao, J., & Feng, J. (2003) · PubMed · Cited by 285
Shimura, H., Hattori, N., Kubo, S.-I., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<668::aid-ana19>3.0.co;2-z · Cited by 282
Ljungberg, T., & Ungerstedt, U. (1976) · Experimental Neurology · doi:10.1016/0014-4886(76)90140-0 · Cited by 269
Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation
Ren, Y., Zhao, J., & Feng, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03316.2003 · Cited by 265
Calabresi, P., Mercuri, N., Stanzione, P., Stefani, A., & Bernardi, G. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90239-9 · Cited by 262
Familial juvenile Parkinsonism.
Carlier, G., & Jm, D. (1979) · PubMed · Cited by 261
Familial juvenile parkinsonism: Clinical and pathologic study in a family
Takahashi, H., Ohama, E., Suzuki, S., Horikawa, Y., Ishikawa, A., Morita, T., Tsuji, S., & Ikuta, F. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.437 · Cited by 258
APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout Mice
Yu, H., Saura, C. A., Choi, S.-Y., Sun, L. D., Yang, X., Handler, M., Kawarabayashi, T., Younkin, L., Fedeles, B., Wilson, M. A., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00417-2 · Cited by 256
Self-citationClinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
van de Warrenburg, B. P. C., Lammens, M., Lücking, C. B., Denèfle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A., & Horstink, M. W. I. M. (2001) · Neurology · doi:10.1212/wnl.56.4.555 · Cited by 255
Corti, O. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg159 · Cited by 244
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: Expanding the phenotype
Klein, C., Pramstaller, P. P., Kis, B., Page, C. E., Kann, M., Leung, J., Woodward, H., Castellan, C. C., Scherer, M., Vieregge, P., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200007)48:1<65::aid-ana10>3.0.co;2-l · Cited by 243
Do environmental toxins cause Parkinson's disease? A critical review.
Tanner, C. M., & Langston, J. (1990) · PubMed · Cited by 230
Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Facilitated Glutamatergic Transmission in the Striatum of D2Dopamine Receptor-Deficient Mice
Cepeda, C., Hurst, R. S., Altemus, K. L., Flores-Hernández, J., Calvert, C. R., Jokel, E. S., Grandy, D. K., Low, M. J., Rubinstein, M., Ariano, M. A., et al. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.659 · Cited by 203
Self-citationComplex relationship between Parkin mutations and Parkinson disease
West, A., Periquet, M., Lincoln, S., Lücking, C. B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10525 · Cited by 203
Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices
Levine, M. S., Li, Z., Cepeda, C., Cromwell, H. C., & Altemus, K. L. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199609)24:1<60::aid-syn7>3.0.co;2-e · Cited by 200
Fallon, L., Moreau, F., Croft, B. G., Labib, N., Gu, W.-J., & Fon, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109806200 · Cited by 190
Papassotiropoulos, A., Bagli, M., Jessen, F., Bayer, T. A., Maier, W., Rao, M. L., & Heun, R. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<666::aid-ana18>3.0.co;2-3 · Cited by 186
Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum
Schallert, T. J., Upchurch, M. B., Wilcox, R. E., & Vaughn, D. M. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90019-9 · Cited by 152
Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices
Levine, M. S., Li, S., Cepeda, C., Cromwell, H. C., & Altemus, K. L. (1996) · Synapse · doi:10.1002/syn.890240102 · Cited by 139
Self-citationQuantitative approaches to in vivo brain microdialysis.
Parsons, L. H., & Justice, J. B. (1994) · PubMed · Cited by 127
Murphy, N. P., Lam, H. A., & Maidment, N. T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00599.x · Cited by 118
Self-citationEvaluation of Nigrostriatal Dopaminergic Function in Adult +/+ and +/− BDNF Mutant Mice
Dluzen, D. E., Gao, X., Story, G. M., Anderson, L. I., Kučera, J., & Walro, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7698 · Cited by 102
Transgenic mouse models of Alzheimer's disease
Hock, B. J., & Lamb, B. T. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02449-0 · Cited by 102
Motor impairments after methamphetamine-induced neurotoxicity in the rat.
Walsh, S. L., & Wagner, G. C. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10392-3 · Cited by 86
Kitada, T., Asakawa, S., Minoshima, S., Mizuno, Y., & Shimizu, N. (2000) · Mammalian Genome · doi:10.1007/s003350010080 · Cited by 76
Role of Mitochondria in Parkinson Disease
Kösel, S., Hofhaus, G., Maassen, A., Vieregge, P., & Graeber, M. B. (1999) · Biological Chemistry · doi:10.1515/bc.1999.106 · Cited by 70
Characterization of Two [3H]Ketanserin Recognition Sites in Rat Striatum
Roth, B. L., McLean, S., Zhu, X. ‐., & Chuang, D. ‐. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb02444.x · Cited by 66
Self-citationA new motor test sensitive to aging and dopaminergic function
Drucker-Colín, R., & García-Hernández, F. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90081-a · Cited by 64
Cosford, R. J. O., Vinson, A. P., Kukoyi, S., & Justice, J. B. (1996) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(96)00057-x · Cited by 55
The Genomic Structure and Promoter Region of the Human Parkin Gene
Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., Kawasaki, K., Mungall, A. J. J., Beck, S., Minoshima, S., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5490 · Cited by 47
Central Nervous System Diseases
(2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.2.176 · Cited by 43
Progress in the clinical and molecular genetics of familial parkinsonism
Kitada, T., Asakawa, S., Matsumine, H., Hattori, N., Shimura, H., Minoshima, S., Shimizu, N., & Mizuno, Y. (2000) · Neurogenetics · doi:10.1007/s100489900083 · Cited by 41
The Cellular Protein Level of Parkin Is Regulated by Its Ubiquitin-like Domain
Finney, N., Walther, F., Mantel, P.-Y., Stauffer, D., Rovelli, G., & Dev, K. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300051200 · Cited by 40
Schallert, T. J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb32972.x · Cited by 38
Reduction of motor impairment by adrenal medulla transplants in aged rats
García-Hernández, F., Pacheco-Cano, M. T., & Drucker-Colı́n, R. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90254-d · Cited by 10
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Rubinstein, A. (2000) · doi:10.1002/(sici)1526-968x(200001)26:1
Research works printed but not linked: 4
- Tanner, 1990, Neurology, 40, 17
- Parsons, 1994, Crit. Rev. Neurobiol., 8, 189
- Walsh, 1992, J. Pharmacol. Exp. Ther., 263, 617
- Schallert, 1988, Vol. 515, 108
Cited by
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
“The first two Parkin-KO mouse models lacked exon 3 and exhibited only mild phenotypes, such as the disruption of fine motor skills and slight abnormalities in dopamine metabolism and release, but, disappointingly, no dopaminergic neuron loss (Goldberg et al., 2003; Itier et al., 2003).”
BackgroundPINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616
“The interplay between PINK1 and Parkin in mitochondrial functioning also may modulate the trafficking of mitochondria in dendrites, perhaps accounting for the synaptic dysfunction that is observed in PINK1- or Parkin-knockout mice (22, 23).”
BackgroundAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287
RetractedMOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
“Two of the knockouts show subtle behavioral deficits, mild alterations of dopaminergic and glutamatergic neurotransmission, and abnormalities in dopamine metabolism (Goldberg et al. 2003, Itier et al. 2003).”
Background
Metadata
- Authors
- Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., Gajendiran, M., Roth, B. L., Chesselet, M.-F., Maidment, N. T., Levine, M. S., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- University of California, Los Angeles (US)
- Case Western Reserve University (US)
- Corresponding author
- Shen, Jie
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 278
- Issue
- 44
- Pages
- 43628-43635
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2088962120
- Cited by
- 913
- References
- 72
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 35 · 2023: 27 · 2022: 45 · 2021: 39 · 2020: 39 · 2019: 25 · 2018: 39 · 2017: 40 · 2016: 29 · 2015: 34 · 2014: 41 · 2013: 43 · 2012: 36
- FWCI
- 33.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6206 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkin, Parkinson's disease, nigrostriatal pathway, dopaminergic neurons, substantia nigra, striatum, dopaminergic modulation, synaptic excitability, spiny neurons, E3 ubiquitin ligase, alpha-synuclein, synphilin-1, neuronal survival
- MeSH terms
- Alleles, Animals, Behavior, Animal, Brain, Chromatography, High Pressure Liquid, Disease Models, Animal, Dopamine, Electrophysiology, Mice, Transgenic, Models, Genetic, Neurons, Parkinson Disease, Receptors, Dopamine, Substantia Nigra, Time Factors, Blotting, Western, Germ-Line Mutation, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.